Collectively our observations suggest that bazedoxifene could be readily repurposed for the treatment of gastric and colon cancers and that bazedoxifene serves as a tool compound for further chemical refinements to increase specificity and affinity of future small molecule IL11 signaling antagonists. The gene discussed is IL11; the disease is colonic neoplasm.